Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Clinical challenges related to novel oral anticoagulants: drug-drug interactions and monitoring.

× No keyword cloud information.

2 in total

1. Rivaroxaban versus warfarin in nonvalvular atrial fibrillation.

Authors: Manesh R Patel; Kenneth W Mahaffey; Jyotsna Garg; Guohua Pan; Daniel E Singer; Werner Hacke; Günter Breithardt; Jonathan L Halperin; Graeme J Hankey; Jonathan P Piccini; Richard C Becker; Christopher C Nessel; John F Paolini; Scott D Berkowitz; Keith A A Fox; Robert M Califf
Journal: N Engl J Med Date: 2011-08-10 Impact factor: 91.245

2. Rivaroxaban: population pharmacokinetic analyses in patients treated for acute deep-vein thrombosis and exposure simulations in patients with atrial fibrillation treated for stroke prevention.

Authors: Wolfgang Mueck; Anthonie W A Lensing; Giancarlo Agnelli; Hervé Decousus; Paolo Prandoni; Frank Misselwitz
Journal: Clin Pharmacokinet Date: 2011-10 Impact factor: 6.447

2 in total

14 in total

Review 1. Drug-drug interactions in an era of multiple anticoagulants: a focus on clinically relevant drug interactions.

Authors: Sara R Vazquez
Journal: Hematology Am Soc Hematol Educ Program Date: 2018-11-30

2. Prescribing of NOACs has outnumbered warfarin: exploring how physicians choose anticoagulant treatments.

Authors: Anne Katrine Eek; Erik Øie; Anne Gerd Granas
Journal: Eur J Clin Pharmacol Date: 2017-11-17 Impact factor: 2.953

3. NOACs: drug-drug interactions.

Authors: Bartosz Hudzik; Andrzej Lekston; Mariusz Gasior
Journal: CMAJ Date: 2016-03-15 Impact factor: 8.262

Review 4. Who Should Be Referred for Left Atrial Appendage Occlusion Therapy?

Authors: Sidakpal S Panaich; David R Holmes
Journal: Curr Treat Options Cardiovasc Med Date: 2017-06

Review 5. Drug Interactions in Neurocritical Care.

Authors: Brian Spoelhof; Salia Farrokh; Lucia Rivera-Lara
Journal: Neurocrit Care Date: 2017-10 Impact factor: 3.210

Review 6. Drug Interactions Affecting Oral Anticoagulant Use.

Authors: Philip L Mar; Rakesh Gopinathannair; Brooke E Gengler; Mina K Chung; Arturo Perez; Jonathan Dukes; Michael D Ezekowitz; Dhanunjaya Lakkireddy; Gregory Y H Lip; Mike Miletello; Peter A Noseworthy; James Reiffel; James E Tisdale; Brian Olshansky
Journal: Circ Arrhythm Electrophysiol Date: 2022-05-27

Clinical challenges related to novel oral anticoagulants: drug-drug interactions and monitoring.

1. Rivaroxaban versus warfarin in nonvalvular atrial fibrillation.

2. Rivaroxaban: population pharmacokinetic analyses in patients treated for acute deep-vein thrombosis and exposure simulations in patients with atrial fibrillation treated for stroke prevention.

Review 1. Drug-drug interactions in an era of multiple anticoagulants: a focus on clinically relevant drug interactions.

2. Prescribing of NOACs has outnumbered warfarin: exploring how physicians choose anticoagulant treatments.

3. NOACs: drug-drug interactions.

Review 4. Who Should Be Referred for Left Atrial Appendage Occlusion Therapy?

Review 5. Drug Interactions in Neurocritical Care.

Review 6. Drug Interactions Affecting Oral Anticoagulant Use.

7. The Significance of Drug-Drug and Drug-Food Interactions of Oral Anticoagulation.

Review 8. Guidance for the practical management of the direct oral anticoagulants (DOACs) in VTE treatment.

9. Decreased Rivaroxaban Levels in a Patient with Cerebral Vein Thrombosis Receiving Phenytoin.

10. Rivaroxaban for Treatment of Left Ventricular Thrombus: A Case Report.